Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
MIBG plus dinutuximab met of zonder vorinostat bij gerecidiveerd/refractair neuroblastoom
sep 2025 | Neuro-oncologie